The clinical symptoms and MRI characteristics of transverse myelopathy (TM) due to non-compressive causes are reviewed, with special emphasis on the differential diagnosis between inflammatory demyelinating lesions, and metabolic and vascular myelopathies. Inflammatory transverse myelopathies are the commonest and most difficult ones to identify. The differentiation between clinically isolated syndromes, multiple sclerosis, neuromyelitis optica, acute disseminated encephalomyelitis and metabolic causes is based on both clinical symptoms and paraclinical signs including magnetic resonance imaging, cerebrospinal fluid analysis, and immunologic and biochemical parameters. The most intriguing form of TM is that where there is clinical evidence of complete spinal cord transection, with normal findings in magnetic resonance imaging in the acute phase, but subsequent cord atrophy.
Introduction
The clinical symptoms of complete or incomplete transverse myelopathy (TM) indicate the presence of a lesion of the spinal cord in need of urgent therapy. However, the exact diagnosis is often complicated by extensive differential diagnosis (1,2,3,) . Transverse myelopathies may result from pathogeneticaly heterogeneous disorders of the spinal cord.
Although they are most commonly inflammatory in origin, including autoimmune disorders such as systemic lupus erythematosus (4), Sjögren's syndrome (5, 6) , antiphospholipid antibody syndrome (7), mixed connective tissue disease (8) , systemic sclerosis (9), ankylosing spondylitis (10) and sarcoidosis (11) , vascular and metabolic causes are more common than usually suspected. TM can also result from different bacterial or viral infections (12) (13) (14) (15) (16) .
In addition to its rapid clinical development, clues to the exact diagnosis of TM will be obtained from cerebrospinal fluid (CSF) analysis, magnetic resonance imaging (MRI), neurophysiological features and immunological studies. Spinal cord MRI is very important in order to exclude compressive lesions of the spinal cord (17, 18, 19) .
Inflammatory lesions often produce local enlargement of the spinal cord and increased signal intensity on T2 weighted sequences of MRI (17) . However, in some cases it is difficult to differentiate inflammatory lesions from intramedullary tumors, compressive spinal cord diseases (17, 18, 19) , hematomas, and ischemic events. CSF study is mostly useful in identifying bacterial and viral infections; biochemical parameters such as deficiencies of vitamins E and B12, and serum copper levels can rule out other metabolic etiologies of myelopathy.
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Inflammatory myelopathies
Inflammation is not only the commonest basis of TM but is also the most difficult to differentiate. The majority of incomplete TM in young persons are diagnosed as multiple sclerosis (MS) (20, 21, 22) or clinically isolated syndrome (CIS) . This was the case in our previous study where 31 patients with TM: six cases were originally called CIS ,who all later converted to MS (2) . The clinical symptoms in CIS are characterized by dominant and asymmetrical sensory signs and symptoms, mostly paraesthesias, usually slowly spreading from the legs to the upper part of the body, more pronounced on one side, often with a band-like sensation or pressure around the abdomen or chest. MRI is also quite typical with small demyelinating lesions, involving less than two segments, most often located in the posterior or lateral part of the spinal cord (22, 23) (Fig 1) . Patients with MS commonly also have demyelinating lesions of the brain, while in CIS, spinal lesions are the only sign of disease (Fig 1,2 ). There is a small group of patients with isolated spinal cord demyelination and typical relapsing course for many years, sometimes called spinal MS. In MS, and often in CIS oligoclonal bands (OCB) are present in the CSF.
Even in fulminating MS, MRI of the spinal cord is most typical, although brain MRI may point to other differential diagnosis, eg to DEM or granulomatous demyelination as it is seen in presented case ( Fig 3) .
Another diagnostic problem is posed by patients with, more or less symmetrical TM and with long hyperintense MRI lesions, involving three or more segments of the spinal cord, the so-called longitudinal extensive transverse myelitis (LETM). The TM may be associated with optic neuritis. Nowadays such patients are designated as part of the (27, 29) . The finding that some cases of NMO are associated with a highly specific serum autoantibody marker aquaporin-4 antibody, also known as the "NMO-IgG," makes possible to differentiate NMO from MS (27) (28) (29) . Specific serum autoantibody marker (NMO-IgG) against aquaporin 4 derived from peripheral B cells cause the activation of complement, inflammatory demyelination and necrosis typical for NMO (Fig 4) . Whether NMO-IgG titers correlate with disease and attack severity or favorable response to therapy is unknown (30) . As NMO-IgG can be detected at the first attack of myelitis or ON, this suggest that the antibody is more likely an integral part of the pathogenesis of the disease rather than an epiphenomenon of the tissue injury (27, 29, 30) . In seropositive Approximately half the patients with NMO and connective tissue disorders are seropositive for NMO-IgG, whereas patients with SLE or SS who do not have manifestations of NMO are uniformly seronegative (35) (Fig 7) . It is likely that these 8 8 patients have two coexisting autoimmune disorders rather than a vasculitic complication of a systemic autoimmune disease such as SLE or SS (35, 36) . Similarly, NMO may coexist with myasthenia gravis or other systemic autoimmune diseases (37, 38) (Fig 8) .
Parainfectious or postinfectious TM are not rare although the triggering infectious agent is identified in only very few patients (39, 40) . Parainfectious or postvaccinal demyelinating disorders of the CNS are characterized by signs of encephalopathy, meningismus and multifocal signs of CNS dysfunctions, and are diagnosed as acute disseminated encephalomyelitis (ADEM (39, 40) . Brain MRI reveals multiple mediumsized or large white matter lesions, also involving the deep grey matter as well as cortical structures (39) (40) (41) (42) . ADEM may also present as isolated LETM (Fig 9) . The selective involvement of the posterior columnes is, in a way, similar to what is seen in NMO. It suggest that these parts of the CNS are immunologically more vulnerable (39) (40) (41) (42) .
Previous respiratory infection, and mild , monophasic course of the disease of this particular patient point to the diagnosis of ADEM and against NMO. In our previous study of TM, 11 of 31 patients were diagnosed as DEM.
Recently, gadolinium enhancement (GDE) was explained as a diagnostic parameter that may help in differentiating between ADEM and NMO (43, 44) . The former, without lesion enhancement in MRI may represent a manifestation of NMO. The lack of enhancement suggests an intact blood-brain barrier and supports a unique mechanism of edema induction due to dysfunction of water channels (43) . But in some cases, especially in cases with a subacute course, spinal cord demyelination is not followed by GDE 9 9 enhancement(40,41). In such patients right diagnosis is based on follow up , especially in patients without LEMT. Some of these patients (Fig 10) in the future will develop MS.
A different diagnostic problem is encountered in patients who develop a complete transverse spinal syndrome without signs of demyelination or other abnormalities of the spinal cord in MRI. Two such patients were young women. One developed pain in the back after swiming and within a few minutes developed severe flaccid paraparesis and urinary incontinence. Brain and entire spinal cord MRI were normal. After a month she developed severe spastic paraparesis, and her spinal MRI showed only atrophic changes.
The neurologic deficit had remained unchanged. Similar symptoms developed in another young woman, with the sudden onset of paraplegia, urinary incontinence and a sensory level below T9. Spinal and brain MRI were normal. After a few months she still had severe spastic paraparesis with the same sensory level below T9 and atrophy in T10-T11 was identified in spinal cord MRI.
In our previous study four of our 31 patients had the similar osent symptoms and clinical course. (2) Analysis of the CSF in these patients with normal spinal MRI, demonstrated the presence of OCB or elevated protein levels, but no vigorous inflammatory reaction, along with the lack of demyelination, suggest that parenchymatous neurons are the sites of the pathologic involvement, and are are analogous to the acute lesions of axonal polyneuropathy. Such cases could be variants of DEM although similar cases were described in patient with SLE and was regarded as part of NMO spectrum (45) . It was found that about 40% of acute transverse myelopathies cannot be documented by MRI (17)
Metabolic myelopathies
Metabolic myelopathies most commonly occur in patients with vitamin B12 (cyanocobalamin) (Fig. 11) , copper (Cu) and vitamin E deficiencies (46, 47) . The neurological manifestations may be the earliest and not infrequently the only signs of B12 deficiency. They may have a relatively sudden onset, that include spastic paraparesis, impaired perception of joint position and vibration, commonly involving the hands (Fig 11) . The myelopathy may be associated with neuropathy, cognitive impairment and paraesthesias. MRI of the spinal cord typically shows hyperintensive changes, mainly involving the posterior and lateral columns (46) . Contrast enhancement may be present. Cu defiency is caused by low serum copper due to malabsorbtion, gastric surgery, or excessive zinc consumption. The clinical symptoms are characterized by myelopathy that resembles subacute combined degeneration seen in B12 defiency.
MRI similarly shows increased signal involving the dorsal and lateral column (47) .
Vascular myelopathies
Vascular myelopathies may arise from haemorrhage, infarction , a vascular 'steal" syndrome, or venous congestion (48) . Spinal ischaemia may be due to vasculitis (polyarteritis nodosa, Behcet disease, giant cell arteritis), systemic hypoperfusion (in cardiac arrest, aortic rupture, aortic dissecon or coarctation), embolism (atrial myxoma, mitral disease, endocarditis, fibrocartilaginous emboli from a ruputured intervetebraldisc) and infectious causes (syphylitic arteritis, bacterial meningitis ) (48, 49) . The symptoms of spinal cord ishaemia are often stuttering or stepwise, and not necessarily maximal at (Fig 12) .
Diffuse weight imaging (DWI) is promising but mostly not helpful.
Conclusion
The differential diagnosis of TM is complex due to the heterogeneity of the pathological processes. In MS, the most common inflammatory disorder of the spinal cord, the differential diagnosis is relatively simple. Differentiation of NMO, especially of the NMO spectrum is more difficult, and it is especially important to differentiate seronegative NMO from DEM. Spinal cord DEM is remarkably similar in many aspects to NMO. Differentiation according to GDE is unreliable. CSF was normal, OCB were negative, biochemical parameters and immunological work up were unremarkable. After corticosteroid treatment and plasmapheresis he was better, there was no more need for ventilation, and he was partially able to move his extremities.
LEMT with respiratory insufficiency, as well as brain MRI findings pointed to the diagnosis of NMO. The patient presented with the sudden development of severe flaccid tetraparesis and respiratory insufficiency. After one month he was reffered in our department.
Neurological examination revealed flaccid paraparesis of upper extremities and spastic lower paraparesis with incontinence. The MRI lesions of patients with ischemic myelopathy are discontinuous, partially hyperintense and partially hypointense in T2-weighted images as it is seen in this patient.
